Drug pricing investigation: industry spending on buybacks, dividends, and executive compensation : staff report / Committee on Oversight and Reform, U.S. House of Representatives.

Saved in:

Bibliographic Details
Online Access:	Online Access
Format:	Government Document eBook
Language:	English
Published:	[Washington, D.C.] : Committee on Oversight and Reform, U.S. House of Representatives, 2021.
Subjects:	Pharmaceutical industry > Corrupt practices > United States. Stock repurchasing > United States. Drugs > Prices > United States.

Internet

Online Access

Holdings details from Online
Call Number:	Y 4.OV 2:P 93/3
Y 4.OV 2:P 93/3	Available